Methylerythritol phosphate pathway of isoprenoid biosynthesis

Annual Review of Biochemistry

Volumn 82, Issue , 2013, Pages 497-530

  Zhao, Lishan ^a   Chang, Wei Chen ^b   Xiao, Youli ^c   Liu, Hung Wen ^b   Liu, Pinghua ^c  

^a Amyris Inc   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c Boston University   (United States)

Author keywords

Biosynthesis; Enzyme mechanism; Isoprenoids; MEP; Metabolic engineering; Methylerythritol phosphate pathway; Mevalonic acid pathway; MVA; Synthetic biology

Indexed keywords

1 DEOXY DEXTRO XYLULOSE 5 PHOSPHATE REDUCTOISOMERASE; 1 DEOXY DEXTRO XYLULOSE 5 PHOSPHATE SYNTHASE; 4 HYDROXY 3 METHYL BUTENYL 1 DIHOSPHATE REDUCTASE; ARTEMISINIC ACID; ARTEMISININ; DIMETHYLALLYL DIPHOSPHATE ISOMERASE; ENZYME; ISOPRENOID; METHYLERYTHRITOL PHOSPHATE; MEVALONIC ACID; PACLITAXEL; PHOSPHATE; SULFUR; TAXADIEN 5 ALPHA OL; UNCLASSIFIED DRUG; XYLULOSE;

BIOSYNTHESIS; CATALYSIS; ESCHERICHIA COLI; FERMENTATION; MALARIA; METABOLIC ENGINEERING; NONHUMAN; PRIORITY JOURNAL; PROTON TRANSPORT; REACTION ANALYSIS; REVIEW;

BIOSYNTHETIC PATHWAYS; CATALYSIS; ERYTHRITOL; HEMITERPENES; HUMANS; ORGANOPHOSPHORUS COMPOUNDS; TERPENES;

EID: 84878950920     PISSN: 00664154     EISSN: 15454509     Source Type: Book Series    
DOI: 10.1146/annurev-biochem-052010-100934     Document Type: Review

References (162)

1. Ajikumar PK, Tyo K, Carlsen S, Mucha O, Phon TH, Stephanopoulos G. 2008. Terpenoids: opportunities for biosynthesis of natural product drugs using engineered microorganisms. Mol. Pharm. 5:167-90
2. Liu C, Zhao Y, Wang Y. 2006. Artemisinin: current state and perspectives for biotechnological production of an antimalarial drug. Appl. Microbiol. Biotech. 72:11-20
3. Jennewein S, Croteau R. 2001. Taxol: biosynthesis, molecular genetics, and biotechnological applications. Appl. Microbiol. Biotech. 57:13-19
4. Bakkali F, Averbeck S, Averbeck D, Idaomar M. 2008. Biological effects of essential oils - a review. Food Chem. Toxicol. 46:446-75
5. Fraser PD, Bramley PM. 2004. The biosynthesis and nutritional uses of carotenoids. Prog. Lipid Res. 43:228-65
6. Bloch K. 1992. Sterol molecule: structure, biosynthesis, and function. Steroids 57:378-83
7. Bach TJ. 1995. Some new aspects of isoprenoid biosynthesis in plants - a review. Lipids 30:191-202
8. Eisenreich W, Bacher A, Arigoni D, Rohdich F. 2004. Biosynthesis of isoprenoids via the non-mevalonate pathway. Cell. Mol. Life Sci. 61:1401-26
9. Rohmer M. 2007. Diversity in isoprene unit biosynthesis: the methylerythritol phosphate pathway in bacteria and plastids. Pure Appl. Chem. 79:739-51
10. Rohmer M. 1999. The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants. Nat. Prod. Rep. 16:565-74
11. Hale I, O'Neill PM, Berry NG, Odom A, Sharma R. 2012. The MEP pathway and the development of inhibitors as potential anti-infective agents. MedChemComm 3:418-33
12. Obiol-Pardo C, Rubio-Martinez J, Imperial S. 2011. The methylerythritol phosphate (MEP) pathway for isoprenoid biosynthesis as a target for the development of new drugs against tuberculosis. Curr. Med. Chem. 18:1325-38
13. Wiemer AJ, Hsiao CH, Wiemer DF. 2010. Isoprenoid metabolism as a therapeutic target in gramnegative pathogens. Curr. Top. Med. Chem. 10:1858-71
14. Gräwert T, Groll M, Rohdich F, Bacher A, Eisenreich W. 2011. Biochemistry of the non-mevalonate isoprenoid pathway. Cell. Mol. Life Sci. 68:3797-814
15. Rohmer M. 2010. Methylerythritol phosphate pathway. In Comprehensive Natural Products II - Chemistry and Biology, ed. H-w Liu, L Mander, pp. 517-56. Oxford: Elsevier Science
16. Wiesner J, Jomaa H. 2007. Isoprenoid biosynthesis of the apicoplast as drug target. Curr. Drug Targets 8:3-13
17. Grochowski LL, Xu H, White RH. 2006. Methanocaldococcus jannaschii uses a modified mevalonate pathway for biosynthesis of isopentenyl diphosphate. J. Bacteriol. 188:3192-98
18. Chen M, Poulter CD. 2010. Characterization of thermophilic archaeal isopentenyl phosphate kinases. Biochemistry 49:207-17
19. Mabanglo MF, Schubert HL, Chen M, Hill CP, Poulter CD. 2010. X-ray structures of isopentenyl phosphate kinase. ACS Chem. Biol. 5:517-27
20. Dellas N, Noel JP. 2010. Mutation of archaeal isopentenyl phosphate kinase highlights mechanism and guides phosphorylation of additional isoprenoid monophosphates. ACS Chem. Biol. 5:589-601
21. Rohmer M, Knani M, Simonin P, Sutter B, Sahm H. 1993. Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate. Biochem. J. 295(Pt. 2):517-24
22. Schwarz H. 1994. Terpene-biosynthese in Ginkgo biloba: Eine uberraschende Geschichte. Zürich: Eidgen össische Technische Hochschule
23. Kuzuyama T, Takagi M, Takahashi S, Seto H. 2000. Cloning and characterization of 1-deoxy-D-xylulose 5-phosphate synthase from Streptomyces sp. strain CL190, which uses both the mevalonate and nonmevalonate pathways for isopentenyl diphosphate biosynthesis. J. Bacteriol. 182:891-97
24. Hahn FM, Eubanks LM, Testa CA, Blagg BSJ, Baker JA, Poulter CD. 2001. 1-Deoxy-D-xylulose 5-phosphate synthase, the gene product of open reading frame (ORF) 2816 andORF 2895 in Rhodobacter capsulatus. J. Bacteriol. 183:1-11
25. Xiang S, Usunow G, Lange G, Busch M, Tong L. 2007. Crystal structure of 1-deoxy-D-xylulose 5-phosphate synthase, a crucial enzyme for isoprenoids biosynthesis. J. Biol. Chem. 282:2676-82
26. David S, Estramareix B, Fischer JC, Therisod M. 1982. The biosynthesis of thiamine. Syntheses of [1, 1, 1, 5-2H4]-1-deoxy-D-threo-2-pentulose and incorporation of this sugar in biosynthesis of thiazole by Escherichia coli cells. J. Chem. Soc. 1982:2131-37
27. Cane DE, Du S, Robinson JK, Hsiung Y, Spenser ID. 1999. Biosynthesis of vitamin B-6: enzymatic conversion of 1-deoxy-D-xylulose-5-phosphate to pyridoxol phosphate. J. Am. Chem. Soc. 121:7722-23
28. Eubanks LM, Poulter CD. 2003. Rhodobacter capsulatus 1-deoxy-D-xylulose 5-phosphate synthase: steadystate kinetics and substrate binding. Biochemistry 42:1140-49
29. Hoeffler JF, Tritsch D, Grosdemange-Billiard C, Rohmer M. 2002. Isoprenoid biosynthesis via the methylerythritol phosphate pathway - mechanistic investigations of the 1-deoxy-D-xylulose 5-phosphate reductoisomerase. Eur. J. Biochem. 269:4446-57
30. Proteau PJ. 2004. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase: an overview. Bioorg. Chem. 32:483-93
31. Argyrou A, Blanchard JS. 2004. Kinetic and chemical mechanism of Mycobacterium tuberculosis 1-deoxy- D-xylulose-5-phosphate isomeroreductase. Biochemistry 43:4375-84
32. Fox DT, Poulter CD. 2005. Mechanistic studies with 2-C-methyl-D- erythritol 4-phosphate synthase from Escherichia coli. Biochemistry 44:8360-68
33. Wong U, Cox RJ. 2007. The chemical mechanism of D-1-deoxyxylulose-5- phosphate reductoisomerase from Escherichia coli. Angew. Chem. Int. Ed. 46:4926-29
34. Munos JW, Pu X, Mansoorabadi SO, Kim HJ, Liu H-w. 2009. A secondary kinetic isotope effect study of the 1-deoxy-D-xylulose-5-phosphate reductoisomerase-catalyzed reaction: evidence for a retroaldolaldol rearrangement. J. Am. Chem. Soc. 131:2048-49
35. Mac Sweeney A, Lange R, Fernandes RP, Schulz H, Dale GE, et al. 2005. The crystal structure of E. coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation. J. Mol. Biol. 345:115- 27
36. Lauw S, Illarionova V, Bacher A, Rohdich F, Eisenreich W. 2008. Biosynthesis of isoprenoids: studies on the mechanism of 2C-methyl-D-erythritol- 4-phosphate synthase. FEBS J. 275:4060-73
37. Fox DT, Poulter CD. 2005. Synthesis and evaluation of 1-deoxy-D-xylulose 5-phosphoric acid analogues as alternate substrates for methylerythritol phosphate synthase. J. Org. Chem. 70:1978-85
38. Meyer O, Grosdemange-Billiard C, Tritsch D, Rohmer M. 2007. Synthesis and activity of two trifluorinated analogues of 1-deoxy-D-xylulose 5-phosphate. Tetrahedron Lett. 48:711-14
39. Fernandes RPM, Phaosiri C, Proteau PJ. 2005. Mutation in the flexible loop of 1-deoxy-D-xylulose 5-phosphate reductoisomerase broadens substrate utilization. Arch. Biochem. Biophys. 444:159-64
40. Munos JW, Pu X, Liu H-w. 2008. Synthesis and analysis of a fluorinated product analogue as an inhibitor for 1-deoxy-D-xylulose 5-phosphate reductoisomerase. Bioorg. Med. Chem. Lett. 18:3090-94
41. Herz S, Wungsintaweekul J, Schuhr CA, Hecht S, Luttgen H, et al. 2000. Biosynthesis of terpenoids: YgbB protein converts 4-diphosphocytidyl-2C-methyl- D-erythritol 2-phosphate to 2C-methyl- D-erythritol 2, 4-cyclodiphosphate. Proc. Natl. Acad. Sci. USA 97:2486-90
42. Rohdich F, Eisenreich W, Wungsintaweekul J, Hecht S, Schuhr CA, Bacher A. 2001. Biosynthesis of terpenoids. 2C-Methyl-D-erythritol 2, 4-cyclodiphosphate synthase (IspF) from Plasmodium falciparum. Eur. J. Biochem. 268:3190-97
43. Testa CA, Lherbet C, Pojer F, Noel JP, Poulter CD. 2006. Cloning and expression of IspDF from Mesorhizobium loti. Characterization of a bifunctional protein that catalyzes non-consecutive steps in the methylerythritol phosphate pathway. Biochim. Biophys. Acta 1764:85-96
44. Gabrielsen M, Rohdich F, Eisenreich W, Gräwert T, Hecht S, et al. 2004. Biosynthesis of isoprenoids: a bifunctional IspDF enzyme from Campylobacter jejuni. Eur. J. Biochem. 271:3028-35
45. Gabrielsen M, Bond CS, Hallyburton I, Hecht S, Bacher A, et al. 2004. Hexameric assembly of the bifunctional methylerythritol 2, 4-cyclodiphosphate synthase and protein-protein associations in the deoxyxylulose- dependent pathway of isoprenoid precursor biosynthesis. J. Biol. Chem. 279:52753-61
46. Baker J, Franklin DB, Parker J. 1992. Sequence and characterization of the gcpE gene of Escherichia coli. FEMS Microbiol. Lett. 73:175-80
47. Campos N, Rodríguez-Concepción M, Seemann M, Rohmer M, Boronat A. 2001. Identification of gcpE as a novel gene of the 2-C-methyl-D-erythritol 4-phosphate pathway for isoprenoid biosynthesis in Escherichia coli. FEBS Lett. 488:170-3
48. Altincicek B, Kollas AK, Sanderbrand S, Wiesner J, Hintz M, et al. 2001. GcpE is involved in the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis in Escherichia coli. J. Bacteriol. 183:2411-16
49. Hecht S, Eisenreich W, Adam P, Amslinger S, Kis K, et al. 2001. Studies on the nonmevalonate pathway to terpenes: the role of the GcpE (IspG) protein. Proc. Natl. Acad. Sci. USA 98:14837-42
50. Seemann M, Campos N, Rodríguez-Concepción M, Ibañez E, Duvold T, et al. 2002. Isoprenoid biosynthesis in Escherichia coli via the methylerythritol phosphate pathway: enzymatic conversion of methylerythritol cyclodiphosphate into a phosphorylated derivative of (E)-2-methylbut-2-ene-1, 4-diol. Tetrahedron Lett. 43:1413-15
51. Seemann M, Campos N, Rodríguez-Concepción M, Hoeffler J-F, Grosdemange-Billiard C, et al. 2002. Isoprenoid biosynthesis via the methylerythritol phosphate pathway: accumulation of 2-C-methyl-Derythritol 2, 4-cyclodiphosphate in a gcpE deficient mutant of Escherichia coli. Tetrahedron Lett. 43:775-78
52. Zepeck F, Gräwert T, Kaiser J, Schramek N, Eisenreich W, et al. 2005. Biosynthesis of isoprenoids. Purification and properties of IspG protein from Escherichia coli. J. Org. Chem. 70:9168-74
53. Xiao Y, Zahariou G, Sanakis Y, Liu P. 2009. IspG enzyme activity in the deoxyxylulose phosphate pathway: roles of the iron-sulfur cluster. Biochemistry 48:10483-85
54. Johnson DC, Dean DR, Smith AD, Johnson MK. 2005. Structure, function, and formation of biological iron-sulfur clusters. Annu. Rev. Biochem. 74:247-81
55. Loiseau L, Gerez C, Bekker M, Ollagnier-de Choudens S, Py B, et al. 2007. ErpA, an iron-sulfur (Fe-S) protein of the A-type essential for respiratory metabolism in Escherichia coli. Proc. Natl. Acad. Sci. USA 104:13626-31
56. Kollas AK, Duin EC, Eberl M, Altincicek B, Hintz M, et al. 2002. Functional characterization of GcpE, an essential enzyme of the non-mevalonate pathway of isoprenoid biosynthesis. FEBS Lett. 532:432-36
57. Seemann M, Wegner P, Schunemann V, Bui BT, Wolff M, et al. 2005. Isoprenoid biosynthesis in chloroplasts via the methylerythritol phosphate pathway: the (E)-4-hydroxy-3-methylbut-2-enyl diphosphate synthase (GcpE) from Arabidopsis thaliana is a [4Fe-4S] protein. J. Biol. Inorg. Chem. 10:131-37
58. Lee M, Gräwert T, Quitterer F, Rohdich F, Eppinger J, et al. 2010. Biosynthesis of isoprenoids: crystal structure of the [4Fe-4S] cluster protein IspG. J. Mol. Biol. 404:600-10
59. Rekittke I, Nonaka T, Wiesner J, Demmer U, Warkentin E, et al. 2011. Structure of the E-1-hydroxy-2- methyl-but-2-enyl-4-diphosphate synthase (GcpE) from Thermus thermophilus. FEBS Lett. 585:447-51
60. Rees DC, Howard JB. 2003. The interface between the biological and inorganic worlds: iron-sulfur metalloclusters. Science 300:929-31
61. Beinert H, Holm RH, Munck E. 1997. Iron-sulfur clusters: nature's modular, multipurpose structures. Science 277:653-59
62. Puan KJ, Wang H, Dairi T, Kuzuyama T, Morita CT. 2005. fldA is an essential gene required in the 2-C-methyl-D-erythritol 4-phosphate pathway for isoprenoid biosynthesis. FEBS Lett. 579:3802-6
63. Seemann M, Tse Sum Bui B, Wolff M, Miginiac-Maslow M, Rohmer M. 2006. Isoprenoid biosynthesis in plant chloroplasts via the MEP pathway: direct thylakoid/ferredoxin-dependent photoreduction of GcpE/IspG. FEBS Lett. 580:1547-52
64. Okada K, Hase T. 2005. Cyanobacterial non-mevalonate pathway: (E)-4-hydroxy-3-methylbut-2-enyl diphosphate synthase interacts with ferredoxin in Thermosynechococcus elongatus BP-1. J. Biol. Chem. 280:20672-79
65. Xu W, Lees NS, Adedeji D, Wiesner J, Jomaa H, et al. 2010. Paramagnetic intermediates of (E)-4- hydroxy-3-methylbut-2-enyl diphosphate synthase (GcpE/IspG) under steady-state and pre-steady-state conditions. J. Am. Chem. Soc. 132:14509-20
66. Adedeji D, Hernandez H, Wiesner J, Köhler U, Jomaa H, Duin EC. 2007. Possible direct involvement of the active-site [4Fe-4S] cluster of the GcpE enzyme from Thermus thermophilus in the conversion of MEcPP. FEBS Lett. 581:279-83
67. Rohdich F, Zepeck F, Adam P, Hecht S, Kaiser J, et al. 2003. The deoxyxylulose phosphate pathway of isoprenoid biosynthesis: studies on the mechanisms of the reactions catalyzed by IspG and IspH protein. Proc. Natl. Acad. Sci. USA 100:1586-91
68. Itoh T, Nagano T, Sato M, Hirobe M. 1989. Deoxygenation of oxiran compounds to olefins by [Fe4S4(Sc6H5)4]2′ in the presence of NaBH4. Tetrahedron Lett. 30:6387-88
69. Seemann M, Bui BTS, Wolff M, Tritsch D, Campos N, et al. 2002. Isoprenoid biosynthesis through the methylerythritol phosphate pathway: The (E)-4-hydroxy-3-methylbut-2-enyl diphosphate synthase (GcpE) is a [4Fe-4S] protein. Angew. Chem. Int. Ed. 41:4337-39
70. Xiao Y, Rooker D, You Q, Meyers CLF, Liu P. 2011. IspG-catalyzed positional isotopic exchange in methylerythritol cyclodiphosphate of the deoxyxylulose phosphate pathway: mechanistic implications. ChemBiochem 12:527-30
71. Buckel W, Martins BM, Messerschmidt A, Golding BT. 2005. Radical-mediated dehydration reactions in anaerobic bacteria. Biol. Chem. 386:951-59
72. Beinert H, Kennedy MC, Stout CD. 1996. Aconitase as iron-sulfur protein, enzyme, and iron-regulatory protein. Chem. Rev. 96:2335-73
73. Wang W, Li J, Wang K, Huang C, Zhang Y, Oldfield E. 2010. Organometallic mechanism of action and inhibition of the 4Fe-4S isoprenoid biosynthesis protein GcpE (IspG). Proc. Natl. Acad. Sci. USA 107:11189-93
74. Wang W, Wang K, Li J, Nellutla S, Smirnova TI, Oldfield E. 2011. An ENDOR and HYSCORE investigation of a reaction intermediate in IspG (GcpE) catalysis. J. Am. Chem. Soc. 133:8400-3
75. Nyland RL II, Xiao Y, Liu P, Freel Meyers CL. 2009. IspG converts an epoxide substrate analogue to (E)- 4-hydroxy-3-methylbut-2-enyl diphosphate: implications for IspG catalysis in isoprenoid biosynthesis. J. Am. Chem. Soc. 131:17734-35
76. Xiao Y, Nyland RL II, Meyers CL, Liu P. 2010. Methylerythritol cyclodiphosphate (MEcPP) in deoxyxylulose phosphate pathway: synthesis from an epoxide and mechanisms. Chem. Commun. 46:7220-22
77. Brandt W, Dessoy MA, Fulhorst M, Gao W, Zenk MH, Wessjohann LA. 2004. A proposed mechanism for the reductive ring opening of the cyclodiphosphate MEcPP, a crucial transformation in the new DXP/MEP pathway to isoprenoids based on modeling studies and feeding experiments. ChemBiochem 5:311-23
78. Wolff M, Seemann M, Tse Sum Bui B, Frapart Y, Tritsch D, et al. 2003. Isoprenoid biosynthesis via the methylerythritol phosphate pathway: the (E)-4-hydroxy-3-methylbut-2-enyl diphosphate reductase (LytB/IspH) from Escherichia coli is a [4Fe-4S] protein. FEBS Lett. 541:115-20
79. Rohdich F, Hecht S, Gärtner K, Adam P, Krieger C, et al. 2002. Studies on the nonmevalonate terpene biosynthetic pathway: metabolic role of IspH (LytB) protein. Proc. Natl. Acad. Sci. USA 99:1158-63
80. Street IP, Christensen DJ, Poulter CD. 1990. Hydrogen exchange during the enzyme-catalyzed isomerization of isopentenyl diphosphate and dimethylallyl diphosphate. J. Am. Chem. Soc. 112:8577-78
81. Adam P, Hecht S, Eisenreich WG, Kaiser J, Gräwert T, et al. 2002. Biosynthesis of terpenes: studies on 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate reductase. Proc. Natl. Acad. Sci. USA 99:12108-13
82. Gräwert T, Kaiser J, Zepeck F, Laupitz R, Hecht S, et al. 2004. IspH protein of Escherichia coli: studies on iron-sulfur cluster implementation and catalysis. J. Am. Chem. Soc. 126:12847-55
83. Gräwert T, Span I, Eisenreich W, Rohdich F, Eppinger J, et al. 2010. Probing the reaction mechanism of IspH protein by x-ray structure analysis. Proc. Natl. Acad. Sci. USA 107:1077-81
84. Altincicek B, Duin EC, Reichenberg A, Hedderich R, Kollas AK, et al. 2002. LytB protein catalyzes the terminal step of the 2-C-methyl-D-erythritol-4- phosphate pathway of isoprenoid biosynthesis. FEBS Lett. 532:437-40
85. Xiao Y, Chu L, Sanakis Y, Liu P. 2009. Revisiting the IspH catalytic system in the deoxyxylulose phosphate pathway: achieving high activity. J. Am. Chem. Soc. 131:9931-33
86. Seemann M, Janthawornpong K, Schweizer J, Böttger LH, Janoschka A, et al. 2009. Isoprenoid biosynthesis via the MEP pathway: In vivoMössbauer spectroscopy identifies a [4Fe-4S]2+ center with unusual coordination sphere in the LytB protein. J. Am. Chem. Soc. 131:13184-85
87. Ahrens-Botzong A, Janthawornpong K, Wolny JA, Tambou EN, Rohmer M, et al. 2011. Biosynthesis of isoprene units: Mössbauer spectroscopy of substrate and inhibitor binding to the [4Fe-4S] cluster of the LytB/IspH enzyme. Angew. Chem. Int. Ed. 50:11976-79
88. Rekittke I, Wiesner J, Röhrich R, Demmer U, Warkentin E, et al. 2008. Structure of (E)-4-hydroxy-3- methyl-but-2-enyl diphosphate reductase, the terminal enzyme of the non-mevalonate pathway. J. Am. Chem. Soc. 130:17206-7
89. Gräwert T, Rohdich F, Span I, Bacher A, Eisenreich W, et al. 2009. Structure of active IspH enzyme from Escherichia coli provides mechanistic insights into substrate reduction. Angew. Chem. Int. Ed. 48:5756-59
90. Bolm C, Legros J, Le Paih J, Zani L. 2004. Iron-catalyzed reactions in organic synthesis. Chem. Rev. 104:6217-54
91. Span I, Grawert T, Bacher A, Eisenreich W, Groll M. 2012. Crystal structures of mutant IspH proteins reveal a rotation of the substrate's hydroxymethyl group during catalysis. J. Mol. Biol. 416:1-9
92. Wang WX, Wang K, Liu YL, No JH, Li JK, et al. 2010. Bioorganometallic mechanism of action, and inhibition, of IspH. Proc. Natl. Acad. Sci. USA 107:4522-27
93. Wang W, Wang K, Span I, Jauch J, Bacher A, et al. 2012. Are free radicals involved in IspH catalysis? An EPR and crystallographic investigation. J. Am. Chem. Soc. 134:11225-34
94. Xiao Y, Liu P. 2008. IspH protein of the deoxyxylulose phosphate pathway: mechanistic studies with C1-deuterium-labeled substrate and fluorinated analogue. Angew. Chem. Int. Ed. 47:9722-25
95. Xiao Y, Zhao ZK, Liu P. 2008. Mechanistic studies of IspH in the deoxyxylulose phosphate pathway: heterolytic C-O bond cleavage at C4 position. J. Am. Chem. Soc. 130:2164-65
96. Gräwert T, Span I, Bacher A, Groll M. 2010. Reductive dehydroxylation of allyl alcohols by IspH protein. Angew. Chem. Int. Ed. 49:8802-9
97. Xu W, Lees NS, Hall D, Welideniya D, Hoffman BM, Duin EC. 2012. A closer look at the spectroscopic properties of possible reaction intermediates in wild-type and mutant (E)-4-hydroxy-3-methylbut-2-enyl diphosphate reductase. Biochemistry 51:4845-49
98. Chang W-c, Xiao Y, Liu H-w, Liu P. 2011. Mechanistic studies of an IspH-catalyzed reaction: implications for substrate binding and protonation in the biosynthesis of isoprenoids. Angew. Chem. Int. Ed. 50:12304-7
99. Janthawornpong K, Krasutsky S, Chaignon P, Rohmer M, Poulter CD, Seemann M. 2013. Inhibition of IspH, a [4Fe-4S]2+ enzyme involved in the biosynthesis of isoprenoids via the methylerythritol phosphate pathway. J. Am. Chem. Soc. 135:1816-22
100. Xiao Y, Chang WC, Liu HW, Liu P. 2011. Study of IspH, a key enzyme in themethylerythritol phosphate pathway using fluoro-substituted substrate analogues. Org. Lett. 13:5912-15
101. Span I, Wang K, Wang W, Jauch J, Eisenreich W, et al. 2013. Structures of fluoro, amino, and thiol inhibitors bound to the [Fe4S4] protein IspH. Angew. Chem. Int. Ed. 52:2118-21
102. Laupitz R, Gräwert T, Rieder C, Zepeck F, Bacher A, et al. 2004. Stereochemical studies on the making and unmaking of isopentenyl diphosphate in different biological systems. Chem. Biodivers. 1:1367-76
103. Citron CA, Brock NL, Rabe P, Dickschat JS. 2012. The stereochemical course and mechanism of the IspH reaction. Angew. Chem. Int. Ed. 51:4053-57
104. Arigoni D, Eisenreich W, Latzel C, Sagner S, Radykewicz T, et al. 1999. Dimethylallyl pyrophosphate is not the committed precursor of isopentenyl pyrophosphate during terpenoid biosynthesis from 1-deoxyxylulose in higher plants. Proc. Natl. Acad. Sci. USA 96:1309-14
105. Rieder C, Jaun B, Arigoni D. 2000. On the early steps of cineol biosynthesis in Eucalyptus globulus. Helv. Chim. Acta 83:2504-13
106. Tritsch D, Hemmerlin A, Bach TJ, Rohmer M. 2010. Plant isoprenoid biosynthesis via theMEPpathway: in vivo IPP/DMAPP ratio produced by (E)-4-hydroxy-3-methylbut-2-enyl diphosphate reductase in tobacco BY-2 cell cultures. FEBS Lett. 584:129-34
107. Agranoff BW, Eggerer H, Henning U, Lynen F. 1959. Isopentenyl pyrophosphate isomerase. J. Am. Chem. Soc. 81:1254-55
108. Agranoff BW, Eggerer H, Henning U, Lynen F. 1960. Biosynthesis of terpenes. VII. Isopentenyl pyrophosphate isomerase. J. Biol. Chem. 235:326-32
109. Kaneda K, Kuzuyama T, Takagi M, Hayakawa Y, Seto H. 2001. An unusual isopentenyl diphosphate isomerase found in the mevalonate pathway gene cluster from Streptomyces sp. strain CL190. Proc. Natl. Acad. Sci. USA 98:932-37
110. Hemmi H, Ikeda Y, Yamashita S, Nakayama T, Nishino T. 2004. Catalytic mechanism of type 2 isopentenyl diphosphate:dimethylallyl diphosphate isomerase: verification of a redox role of the flavin cofactor in a reaction with no net redox change. Biochem. Biophys. Res. Commun. 322:905-10
111. Kittleman W, Thibodeaux CJ, Liu YN, Zhang H, Liu H-w. 2007. Characterization and mechanistic studies of type II isopentenyl diphosphate:dimethylallyl diphosphate isomerase from Staphylococcus aureus. Biochemistry 46:8401-13
112. Rothman SC, Helm TR, Poulter CD. 2007. Kinetic and spectroscopic characterization of type II isopentenyl diphosphate isomerase from Thermus thermophilus: evidence for formation of substrate-induced flavin species. Biochemistry 46:5437-45
113. Thibodeaux CJ, Mansoorabadi SO, Kittleman W, Chang W-C, Liu H-W. 2008. Evidence for the involvement of acid/base chemistry in the reaction catalyzed by the type II isopentenyl diphosphate/dimethylallyl diphosphate isomerase from Staphylococcus aureus. Biochemistry 47:2547-58
114. Johnston JB, Walker JR, Rothman SC, Poulter CD. 2007. Type-2 isopentenyl diphosphate isomerase. Mechanistic studies with cyclopropyl and epoxy analogues. J. Am. Chem. Soc. 129:7740-41
115. Rothman SC, Johnston JB, Lee S, Walker JR, Poulter CD. 2008. Type II isopentenyl diphosphate isomerase: irreversible inactivation by covalent modification of flavin. J. Am. Chem. Soc. 130:4906-13
116. Unno H, Yamashita S, Ikeda Y, Sekiguchi S, Yoshida N, et al. 2009. New role of flavin as a general acid-base catalyst with no redox function in Type 2 isopentenyl-diphosphate isomerase. J. Biol. Chem. 284:9160-67
117. Kao CL, Kittleman W, Zhang H, Seto H, Liu H-w. 2005. Stereochemical analysis of isopentenyl diphosphate isomerase type II from Staphylococcus aureus using chemically synthesized (S)- and (R)- [2-2H]isopentenyl diphosphates. Org. Lett. 7:5677-80
118. Thibodeaux CJ, Chang W-C, Liu H-w. 2010. Linear free energy relationships demonstrate a catalytic role for the flavinmononucleotide coenzyme of the type II isopentenyl diphosphate:dimethylallyl diphosphate isomerase. J. Am. Chem. Soc. 132:9994-96
119. Walker JR, Rothman SC, Poulter CD. 2008. Synthesis and evaluation of substrate analogues as mechanism-based inhibitors of type II isopentenyl diphosphate isomerase. J. Org. Chem. 73:726-29
120. Nagai T, Unno H, Janczak MW, Yoshimura T, Poulter CD, Hemmi H. 2011. Covalent modification of reduced flavin mononucleotide in type-2 isopentenyl diphosphate isomerase by active-site-directed inhibitors. Proc. Natl. Acad. Sci. USA 108:20461-66
121. Hoshino T, Tamegai H, Kakinuma K, Eguchi T. 2006. Inhibition of type 2 isopentenyl diphosphate isomerase from Methanocaldococcus jannaschii by amechanism-based inhibitor of type 1 isopentenyl diphosphate isomerase. Bioorg. Med. Chem. 14:6555-59
122. Calveras J, Thibodeaux CJ, Mansoorabadi SO, Liu H-w. 2012. Stereochemical studies of the type II isopentenyl diphosphate-dimethylallyl diphosphate isomerase implicate theFMNcoenzyme in substrate protonation. ChemBiochem 13:42-46
123. Breitmaier E. 2006. Terpenes: Flavors, Fragrances, Pharmaca, Pheromones. Weinheim, Ger. : WILEY-VCH 223 pp.
124. Barkovich R, Liao JC. 2001. Metabolic engineering of isoprenoids. Metab. Eng. 3:27-39
125. Fu P, Panke S. 2009. Systems Biology and Synthetic Biology. Weinheim, Ger. : WILEY-VCH
126. Tyo KE, Alper HS, Stephanopoulos GN. 2007. Expanding the metabolic engineering toolbox: more options to engineer cells. Trends Biotechnol. 25:132-37
127. White NJ. 2008. Qinghaosu (artemisinin): the price of success. Science 320:330-34
128. World Health Organ. 2006. Guidelines for the Treatment of Malaria. Geneva: World Health Organ. 253 pp.
129. Van Noorden R. 2010. Demand for malaria drug soars. Nature 466:672-73
130. Hale V, Keasling JD, Renninger N, Diagana TT. 2007. Microbially derived artemisinin: a biotechnology solution to the global problem of access to affordable antimalarial drugs. Am. J. Trop. Med. Hyg. 77:198- 202
131. Martin VJ, Pitera DJ, Withers ST, Newman JD, Keasling JD. 2003. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat. Biotechnol. 21:796-802
132. Newman JD, Marshall J, Chang M, Nowroozi F, Paradise E, et al. 2006. High-level production of amorpha-4, 11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli. Biotechnol. Bioeng. 95:684-91
133. Anthony JR, Anthony LC, Nowroozi F, Kwon G, Newman JD, Keasling JD. 2009. Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4, 11-diene. Metab. Eng. 11:13-19
134. Pitera DJ, Paddon CJ, Newman JD, Keasling JD. 2007. Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metab. Eng. 9:193-207
135. Kizer L, Pitera DJ, Pfleger BF, Keasling JD. 2008. Application of functional genomics to pathway optimization for increased isoprenoid production. Appl. Environ. Microbiol. 74:3229-41
136. Lenihan JR, Tsuruta H, Diola D, Renninger NS, Regentin R. 2008. Developing an industrial artemisinic acid fermentation process to support the cost-effective production of antimalarial artemisinin-based combination therapies. Biotechnol. Prog. 24:1026-32
137. Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, et al. 2006. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440:940-43
138. Donald KA, Hampton RY, Fritz IB. 1997. Effects of overproduction of the catalytic domain of 3-hydroxy- 3-methylglutaryl coenzyme A reductase on squalene synthesis in Saccharomyces cerevisiae. Appl. Environ. Microbiol. 63:3341-44
139. Davies BS, Wang HS, Rine J. 2005. Dual activators of the sterol biosynthetic pathway of Saccharomyces cerevisiae: similar activation/regulatory domains but different response mechanisms. Mol. Cell. Biol. 25:7375-85
140. Westfall PJ, Pitera DJ, Lenihan JR, Eng D, Woolard F, et al. 2012. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc. Natl. Acad. Sci. USA 109:E111-18
141. van Dijken JP, Bauer J, Brambilla L, Duboc P, Francois JM, et al. 2000. An interlaboratory comparison of physiological and genetic properties of four Saccharomyces cerevisiae strains. Enzyme Microb. Technol. 26:706-14
142. Hovland P, Flick J, Johnston M, Sclafani RA. 1989. Galactose as a gratuitous inducer of GAL gene expression in yeasts growing on glucose. Gene 83:57-64
143. Teoh KH, Polichuk DR, Reed DW, Nowak G, Covello PS. 2006. Artemisia annua L. (Asteraceae) trichome-specific cDNAs reveal CYP71AV1, a cytochrome P450 with a key role in the biosynthesis of the antimalarial sesquiterpene lactone artemisinin. FEBS Lett. 580:1411-16
144. Teoh KH, Polichuk DR, Reed DW, Covello PS. 2009. Molecular cloning of an aldehyde dehydrogenase implicated in artemisinin biosynthesis in Artemisia annua. Botany 87:635-42
145. Tsuruta H, Paddon CJ, Eng D, Lenihan JR, Horning T, et al. 2009. High-level production of amorpha- 4, 11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli. PLoS ONE 4:e4489
146. Farmer WR, Liao JC. 2001. Precursor balancing for metabolic engineering of lycopene production in Escherichia coli. Biotechnol. Prog. 17:57-61
147. Kim SW, Keasling JD. 2001. Metabolic engineering of the nonmevalonate isopentenyl diphosphate synthesis pathway in Escherichia coli enhances lycopene production. Biotechnol. Bioeng. 72:408-15
148. Martin VJ, Yoshikuni Y, Keasling JD. 2001. The in vivo synthesis of plant sesquiterpenes by Escherichia coli. Biotechnol. Bioeng. 75:497-503
149. Cane DE, Wu Z, Oliver JS, Hohn TM. 1993. Overproduction of soluble trichodiene synthase from Fusarium sporotrichioides in Escherichia coli. Arch. Biochem. Biophys. 300:416-22
150. Morrone D, Lowry L, Determan MK, Hershey DM, Xu M, Peters RJ. 2010. Increasing diterpene yield with a modular metabolic engineering system in E. coli: comparison of MEV and MEP isoprenoid precursor pathway engineering. Appl. Microbiol. Biotechnol. 85:1893-906
151. Ajikumar PK, Xiao WH, Tyo KE, Wang Y, Simeon F, et al. 2010. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science 330:70-74
152. Huang Q, Roessner CA, Croteau R, Scott AI. 2001. Engineering Escherichia coli for the synthesis of taxadiene, a key intermediate in the biosynthesis of taxol. Bioorg. Med. Chem. 9:2237-42
153. Lill R, Muhlenhoff U. 2008. Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases. Annu. Rev. Biochem. 77:669-700
154. Liger D, Graille M, Zhou CZ, Leulliot N, Quevillon-Cheruel S, et al. 2004. Crystal structure and functional characterization of yeast YLR011wp, an enzyme with NAD(P)H-FMN and ferric iron reductase activities. J. Biol. Chem. 279:34890-97
155. Maury J, Asadollahi MA, Moller K, Schalk M, Clark A, et al. 2008. Reconstruction of a bacterial isoprenoid biosynthetic pathway in Saccharomyces cerevisiae. FEBS Lett. 582:4032-38
156. Rude MA, Schirmer A. 2009. Newmicrobial fuels: a biotech perspective. Curr. Opin. Microbiol. 12:274-81
157. Whited GM, Feher FJ, Benko DA, Cervin MA, Chotani GK, et al. 2010. Technology update: development of a gas-phase bioprocess for isoprene-monomer production usingmetabolic pathway engineering. Ind. Biotechnol. 6:152-63
158. Cane DE. 1990. Enzymatic formation of sesquiterpenes. Chem. Rev. 90:1089-103
159. Chang MC, Eachus RA, Trieu W, Ro DK, Keasling JD. 2007. Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat. Chem. Biol. 3:274-77
160. Zhang F, Rodriguez S, Keasling JD. 2011. Metabolic engineering of microbial pathways for advanced biofuels production. Curr. Opin. Biotechnol. 22:1-9
161. Renninger NS, McPhee DJ. 2008. Fuel compositions comprising farnesane and farnesane derivatives and method of making and using same. U. S. Patent No. 2, 008, 045, 555
162. Tsuruta H, Lenihan JR, Regentin R. 2009. Production of isoprenoids. U. S. Patent No. WO2009042070A2